Table 8. Detailed information on the top 10 clusters.
| Cluster ID | Size | Silhouette | Start | Stop | Duration | Mean | Label |
|---|---|---|---|---|---|---|---|
| 0 | 115 | 0.856 | 2009 | 2022 | 14 | 2017 | Atherosclerotic plaque |
| 1 | 114 | 0.83 | 2011 | 2020 | 10 | 2015 | Bone metastases |
| 2 | 102 | 0.78 | 2003 | 2015 | 13 | 2009 | F-18 NaF |
| 3 | 77 | 0.965 | 2005 | 2017 | 13 | 2011 | Coronary atherosclerosis |
| 4 | 57 | 0.897 | 2008 | 2015 | 8 | 2011 | Prostate cancer |
| 5 | 51 | 0.949 | 2015 | 2021 | 7 | 2019 | Head-to-head comparison |
| 6 | 39 | 0.929 | 2012 | 2021 | 10 | 2016 | Clinical application |
| 7 | 31 | 0.997 | 2004 | 2010 | 7 | 2006 | Miscellaneous cancer |
| 8 | 24 | 1 | 2003 | 2013 | 11 | 2008 | Musculoskeletal disorder |
| 9 | 15 | 0.985 | 2012 | 2017 | 6 | 2014 | Multiple myeloma patient |
F-18 NaF, fluorine-18–labelled sodium fluoride.